Scientific Activities

“18F-FET and 18F-choline PET/CT in patients with MRI-presumed low-grade gliomas: a pilot study” article

Ana Mišir Krpan, Anja Tea Golubić, Maja Baučić, Jakob Nemir, Goran Mrak, Marijan Žuvić, Dražen Huić from University Hospital Center in Zagreb, Croatia together with Marina published their work 18F-FET and 18F-choline PET/CT in patients with MRI-presumed low-grade gliomas: a pilot study in Croatian Medical Journal.   Thank you University Hospital Center Zagreb, Croatia for …

“18F-FET and 18F-choline PET/CT in patients with MRI-presumed low-grade gliomas: a pilot study” article Read More »

Marina Hodolic and our scientific collaborators from Linz, Austria published a new article: Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course

Iason would like to announce that great scientific team from Kepler University Hospital, Linz, Austria Ognian Kalev, Berndt Tomancok, Michael Sonnberger, Markus Hutterer, Daniela Ehrlich, Robert Pichler together with our Marina Hodolic published a new article “Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course” in journal Endokrynologia Polska.   Congratulations!   …

Marina Hodolic and our scientific collaborators from Linz, Austria published a new article: Giant silent corticotrope pituitary adenoma in a patient with complicated clinical course Read More »

The first in human use of our new radiopharmaceutical 68Ga-NT-20.3 (IASOtensin®). Article published!

IASON is very proud to announce that the first in human use of our new radiopharmaceutical 68Ga-NT-20.3 has been performed!   Prof. Dr. Marina Hodolic presents the results in her article   “Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in human use”   …

The first in human use of our new radiopharmaceutical 68Ga-NT-20.3 (IASOtensin®). Article published! Read More »

A new manuscript on 18F-FET (IASOglio®) and 18F-DOPA (IASOdopa®) published in Frontiers in Neuroscience

Our scientific collaborators from Policlinico San Matteo, Pavia, Italy together with Marina realized and presented in the manuscript work   “Effects of photons’ irradiation on 18F-FET and 18F-DOPA uptake by T98G glioblastoma cells”  Article published   Bravi: PASI Francesca, PERSICO Marco Giovanni, MARENCO Manuela, VIGORITO Martina, FACOETTI Angelica, HODOLIC Marina, NANO Rosanna, CAVENAGHI Giorgio, LODOLA …

A new manuscript on 18F-FET (IASOglio®) and 18F-DOPA (IASOdopa®) published in Frontiers in Neuroscience Read More »

IASON´s scientific presentations at EANM 2020

Our innovative scientific work was presented at the European Congress of Nuclear Medicine 2020, delivered as oral presentations:   VASINA, J., HODOLIC, M, JANCALEK, R., MACKERLE, Z., HENDRYCH, M., et al. 18F-FET of 18F-FLT PET/CT in diagnosis of low-grade gliomas? A pilot study.   BOSSERT, I., HODOLIC, M, CHYTIRIS, S, D’AMBROSIO, D., MARCHETTO, A., et …

IASON´s scientific presentations at EANM 2020 Read More »

European Medical Journal Oncology published IASON´s work in collaboration with the University Medical Centre Zagreb, Croatia

Journal final EMJ-Radiology-article-Marina Hodolic “18F-FET or 18F-FCH PET/CT in the primary diagnosis of low-grade glioma: a pilot study”   HODOLIC Marina, MISIR KRPAN Ana, GOLUBIC Anja, BAUCIC BOZIC Maja, NEMIR Jakob, MRAK Goran, ZUVIC Marijan and HUIC Drazen, continue the scientific collaboration between IASON and its valuable customers!

New Manuscript on Neurotensin: “Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer”

We are very happy to announce the publication of a new manuscript, written by Marina Hodolic, Valentina Ambrosini and Stefano Fanti, on the ‘Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer’ (see excerpt here). IASON is pleased that this article was announced as ‘Highlight article of the current issue’ …

New Manuscript on Neurotensin: “Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer” Read More »

Do you want to know more about our products?

For inquiries please contact us, we will be happy to assist you!

Scroll to Top